Target intelligence / Profile preview

Collagen and organic matrix in dentin and bone

Molecular classification
Structural protein, Extracellular matrix component
01

Overview

The organic matrix of dentin and bone is a complex structural framework predominantly composed of Type I collagen (approximately 90%) and various non-collagenous proteins such as dentin sialophosphoprotein (DSPP) and osteocalcin (StatPearls, 2023). This matrix serves as the essential template for the deposition of hydroxyapatite crystals, providing hard tissues with their characteristic tensile strength and fracture resistance (PubMed, PMID: 22622760). In clinical dentistry, the preservation of this matrix is critical for the longevity of resin-dentin bonds, as degradation by endogenous enzymes like matrix metalloproteinases (MMPs) can lead to restoration failure (PubMed, PMID: 21247661). In bone, the matrix undergoes constant remodeling by osteoblasts and osteoclasts, a process targeted by pharmacological agents to treat metabolic bone diseases (NIH, 2022). Therapeutic strategies often focus on stabilizing the collagen network through cross-linking agents or preventing its breakdown to maintain structural integrity (PubMed, PMID: 25603115). Furthermore, the interaction between the organic matrix and the mineral phase is a dynamic process that influences the overall bio-mechanical properties of the skeletal and dental systems (PubChem, 2024).

Other names
Dentin organic matrixBone organic matrixType I collagen scaffoldHard tissue extracellular matrix
02

Mechanism of action

Stabilization of the collagenous framework through chemical cross-linking or the inhibition of endogenous proteolytic enzymes (MMPs and cathepsins) to prevent matrix degradation and maintain structural integrity.

03

Biological functions

Structural supportMineralization templateMechanical strengthCell signaling and adhesion
04

Disease associations

Osteogenesis imperfectaDentinogenesis imperfectaOsteoporosisDental cariesPeriodontitis
05

Safety considerations

Potential cytotoxicity of synthetic cross-linking agentsRisk of over-mineralization and increased brittlenessInhibition of physiological tissue remodelingBiocompatibility issues with exogenous chemical modifiers
06

Interacting drugs

Chlorhexidine

5 more in the full profile.

07

Biomarkers

C-terminal telopeptide of type I collagen (CTX)N-terminal telopeptide of type I collagen (NTX)Dentin sialoprotein (DSP)Bone-specific alkaline phosphatase (BALP)

Beyond the preview

Go deeper on Collagen and organic matrix in dentin and bone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen and organic matrix in dentin and bone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call